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Abstract
Bronchopulmonary dysplasia (BPD) is one of the most common chronic lung diseases in infants caused by pre-
and/or postnatal lung injury. BPD is characterized by arrested alveolarization and vascularization due to extracellular
matrix remodeling, inflammation, and impaired growth factor signaling. WNT signaling is a critical pathway for
normal lung development, and its altered signaling has been shown to be involved in the onset and progression of
incurable chronic lung diseases in adulthood, such as chronic obstructive pulmonary disease (COPD) or idiopathic
pulmonary fibrosis (IPF). In this review, we summarize the impact of WNT signaling on different stages of lung
development and its potential contribution to developmental lung diseases, especially BPD, and chronic lung
diseases in adulthood.
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Introduction
Bronchopulmonary dysplasia (BPD) is one of the most
common chronic lung diseases in infants. “Old” or “clas-
sical” BPD was first defined by Northway et al. in 1967
as structural lung damage and subsequent appearance of
parenchymal fibrosis caused by prolonged hyperoxia and
ventilator-associated lung injury during the saccular to
alveolar stage of lung development [1]. Improvement of
clinical neonatal intensive care practices, including
prenatal steroid therapy, exogenous surfactant adminis-
tration, protective lung ventilation strategies, and the
careful monitoring of oxygen supplementation, has led
to a significant reduction in perinatal respiratory-
associated death. With the current clinical practices,
newborns as early as 23 to 26 weeks of gestation are able
to survive; however, these newborns present with a
distinct form of “new” BPD. The prominent new BPD
comprises arrested alveolarization and vascularization,
due to the impact of different risk factors on the func-
tionally and structurally immature lung during the early
canalicular and saccular periods of lung development
[2]. Risk factors include hyperoxia-induced oxygen tox-
icity, mechanical ventilation-induced lung injury, and in-
fection/inflammation of the lungs, which results in
aberrant lung development due to extensive remodeling
of the extracellular matrix (ECM), perturbations of in-
flammatory response, and impaired growth factor signal-
ing [3]. Newborns which have survived and developed
new BPD are approaching adolescence and adulthood.
Several longitudinal studies following patients with new
BPD have demonstrated a decline of forced expiratory
volume in 1 second (FEV1) compared with term-born
controls, reflecting the development of airflow obstruc-
tion in new BPD survivors over time [2, 4–6]. These
data indicate that impairment of alveolarization/
vascularization during childhood, which is a feature of
the new BPD, might contribute to deranged lung alveo-
lar injury/repair processes in adulthood.
Environmental insults, such as smoking, infection, or
hyperoxia, are known to cause aberrant alveolar repair
processes in deranged lung development and also the
adult lung [7, 8]. These environmental insults contribute
not only BPD but also other childhood respiratory dis-
eases including bronchial asthma. A better understanding
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of the processes and signaling pathways altered by these
insults are clearly needed.
Impaired signaling of essential lung development path-
ways, such as fibroblast growth factor (FGF) [9, 10],
Wingless/integrase-1 (WNT) signaling [11], or bone mor-
phogenetic proteins (BMPs) [12], have been reported to
contribute to the pathogenesis of adult chronic lung dis-
eases, such as chronic obstructive pulmonary disease
(COPD) or idiopathic pulmonary fibrosis (IPF) [13]. Of par-
ticular interest, WNT signaling has been linked to aberrant
alveolar epithelial injury and repair processes [11, 14–17].
Because these pathways are mostly attributed to lung devel-
opment and are normally thought to be quiescent in the
adult lung, this raises the question of why these pathways
become aberrant in the adult and whether pre- or postnatal
insults impact developmental signal activity early on, thus
contributing to an increased susceptibility for chronic lung
diseases later in life [7, 18]. In this review, we focus on the
potential role of WNT signaling in lung development and
perinatal lung disease, with a focus on BPD, as a disease of
impaired alveolarization/vascularization, and discuss the
potential link between perinatal and adult chronic lung dis-
eases, such as COPD and IPF.
Review
Overview of WNT signaling
WNT signaling is a critical pathway for embryonic de-
velopment and adult cellular injury and repair processes.
There are at least three well-known WNT pathways: ca-
nonical (β-catenin dependent) signaling and two non-
canonical pathways, (i) planar cell polarity (PCP) and (ii)
Ca2+-calmodulin-dependent protein kinase II (Camk II)/
protein kinase C (PKC) signaling. As shown in Fig. 1, ca-
nonical WNT/β-catenin signaling mainly consists of; (i)
WNT ligands, (ii) the transmembrane receptors, Frizzled
(FZD1–10), (iii) the co-receptors low-density lipoprotein
Fig. 1 Overview of WNT/β-catenin signaling. Without WNT signaling (“WNT OFF”), “destruction complex phosphorylates cytosolic β-catenin and
phosphorylated β-catenin is recognized and degraded by the proteasomes. With WNT signaling (“WNT ON”), the function of “destruction complex”
is inhibited to phosphorylate cytosolic β-catenin. Then unphosphorylated β-catenin accumulates in the cytosol, translocates into the nucleus, and
activates the WNT target gene expression, such as the T-cell factor and lymphoid enhancer factor-1 (TCF/LEF1) family of transcription factors
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receptor-related proteins (LRP) 5 and 6, (iv) signaling
intermediates, Dishevelleds (DVL1–3), (v) the β-catenin
“destruction complex”, (vi) the transcriptional co-
activator, β-catenin, and (vii) the transcription factors, T
cell factor and lymphoid enhancer factor (TCF/LEF).
Extracellular modulators, such as Dickkopfs (DKK1–4),
WNT-inhibitory factor-1 (WIF1), or secreted Frizzled-
related proteins (SFRPs), are also important for regulation
of the pathway. In the absence of WNT ligands, β-catenin
is phosphorylated by the destruction complex, which is
comprised of Axin, adenomatous polyposis coli (APC),
glycogen synthase kinase-3 beta (GSK-3β), and casein
kinase-1 (CK1). Phosphorylated β-catenin is recognized
and ubiquitinated by ubiquitin ligase E3 and subsequently
degraded by the proteasome. Upon WNT ligand binding
to its receptors, the capacity of the destruction complex to
phosphorylate cytosolic β-catenin is inhibited. Unpho-
sphorylated β-catenin accumulates in the cytosol, translo-
cates into the nucleus, and activates WNT target gene
expression, via its integration with the TCF/LEF family of
transcription factors, which is important for cellular pro-
liferation, differentiation, and survival [11, 19, 20].
Non-canonical WNT signaling (i.e., β-catenin inde-
pendent) mainly consists of (i) the WNT/PCP pathway,
which activates c-Jun-N-terminal kinase (JNK) and pro-
teins associated with cytoskeleton rearrangement, and
(ii) the WNT/Ca2+ pathway, activating Camk II, PKC,
the transcription factor nuclear factor of activated T cells
(NFAT), and several other (less well defined) transcrip-
tion factors [19]. In this review, we primarily focus on
the canonical WNT/β-catenin signaling, which has been
investigated most extensively so far.
Lung development and WNT signaling
Historically, a large portion of our knowledge about lung
development has been obtained by using wild-type or
transgenic mice [21]. In the mouse lung, embryonic lung
development starts as early as E9.5 (equivalent to 4 weeks
in human gestation), with tightly coordinated epithelial
and mesenchymal differentiation processes, and is com-
pleted postnatally. At this time point, Nkx2.1, a critical
homeodomain-containing transcription factor for initial
respiratory specification, is expressed within endoderm
progenitors in the anterior foregut [21]. Dorsal-ventral
specification occurs according to signals, such as BMPs,
FGFs, or WNTs, from the surrounding mesenchyme,
endoderm, or mesoderm. Primary lung buds generate
tree-like structures for branching morphogenesis from
E9.5 to E16.5 (in human, 4 to 16 weeks, historically
called the “pseudoglandular stage”), followed by the
“canalicular stage” (E16.5–17.5 in mouse, 16 to 24 weeks
in humans) when terminal sacs are formed, the “saccular
stage” (E17.5 to postnatal day 5 in mouse, 24 to 36 weeks
in human) when distal airways are developed for the
alveoli, and the “alveolar stage” (postnatal day 5 to 30 in
mouse, 36 weeks and after delivery in human) when sec-
ondary alveolar septa are formed to further divide the
airspaces into definitive alveoli (Fig. 2).
WNT signaling is active and highly controlled in a
spatio-temporal fashion throughout murine lung endo-
derm specification in the foregut as well as cellular pro-
liferation and differentiation during lung development
[21–24]. In the mouse lung, several loss- or gain-of-
function studies revealed the importance of WNT signal-
ing in lung morphogenesis [25, 26]. Here, we review the
role of active WNT signaling during murine lung devel-
opment (summarized in Table 1).
WNT ligands and their receptors in the developing mouse
lung
A number of WNT ligands and receptors have been
identified as being critical for various stages of develop-
ment. Deletion of the canonical Wnt2 ligand causes
mouse lung hypoplasia whereas Wnt2/2b double knock-
out leads to complete lung agenesis in mice with a loss
of Nkx2.1 in early embryonic development in the region
where the lung buds are derived from the foregut. Thus
Wnt2 and 2b are required to specify the Nkx2.1-
expressed lung progenitors in the foregut through ca-
nonical WNT/β-catenin signaling [27, 28]. Similarly,
deletion of murine Wnt7b results in hypoplastic lungs
with a proportionate decrease in the replication of both
epithelial and mesenchymal progenitors [29]. The non-
canonical Wnt4 was reported to be expressed in the an-
terior trunk mesoderm and was found to be essential for
proper lung morphogenesis and trachea formation. In
Wnt4 knockout mice, reduced mesodermal proliferation
in the lung bud leads to severe lung hypoplasia and tra-
cheal abnormalities [30]. Moreover, Wnt5a, another lig-
and of non-canonical WNT signaling, has been detected
as early as E12 at both epithelial and mesenchymal com-
partment of the developing lung. The absence of Wnt5a
activity is associated with the overbranching of distal air-
ways in murine E15–16 lung together with an architec-
tural immaturity of the capillaries and alveolar airspaces
[31]. Vice versa, Wnt5a overexpression in the distal epi-
thelium results in reduced epithelial branching and di-
lated distal airways [32]. These data highlight that both
canonical as well as non-canonical signal aberrations
affect normal lung development.
In addition to WNT ligands, the receptors have also
been shown to be important for proper lung develop-
ment. Tissue-specific analysis of the WNT receptors
from E12.5 to E16.5 revealed FZD1, 4, and 7 to be pri-
marily expressed in the developing mouse lung mesen-
chyme and FZD10 in distal airway epithelium and the
expression of those receptors decreases after E14.5 [33].
FZD2 is also highly expressed in distal airways [34], and
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epithelium-specific deletion of Fzd2 causes formation of
cysts in distal airways and defective branching morpho-
genesis [35]. Furthermore, FZD8 is expressed through-
out the pulmonary epithelium [36]. Both LRP5 and
LRP6 are expressed in the upper airway epithelium, and
LRP5, but not LRP6, is also expressed in the smooth
muscle compartment of large vessels [33]. Loss of Lrp5
inhibits angiogenesis and alveolar formation in neonatal
mice in the alveolar stage of lung development [37].
While these data further underline the importance of
WNT signaling during development, much less is known
how these receptors are distinctly involved in canonical
versus non-canonical WNT signaling. Furthermore, fu-
ture studies elucidating cell-specific expression under
(patho-) physiologic conditions are needed.
β-Catenin in normal lung development
Studies modulating the major effector protein of canon-
ical WNT signaling, β-catenin, revealed that both epithe-
lial and mesenchymal β-catenin is required for the onset
of lung specification and the proximal-distal patterning
of branching morphogenesis: deletion of β-catenin in the
foregut leads to the loss of Nkx2.1 expression and the
absence of both the trachea and lung due to a lack of re-
spiratory lineage initiation [27, 38]. Lung epithelium-
specific deletion of β-catenin caused disruption of distal
but not proximal airways in the later stages of lung devel-
opment [28]. On the other hand, conditional knockout of
β-catenin in mesenchymal cells resulted in a shortened
trachea and reduced branching morphogenesis in E12.5 to
E14.5 lungs [23]. In addition to the localization, the timing
Fig. 2 Developmental stages and the WNT/β-catenin signaling. In the embryonic stage (<E9.5 in mouse, <4 weeks in human), Wnt2/2b is
expressed within surrounding mesenchyme for the anterior foregut specification and the onset of lung specification. In the pseudoglandular
stage (E9.5 to 16.5 in mouse, 4 to 16 weeks in human), several Wnt ligands, receptors, and extracellular modulators are expressed within proximal
or distal airways and surrounding mesenchyme and coordinate proximal-distal patterning of branching morphogenesis. In the canalicular stage
(E16.5 to 17.5 in mouse, 16 to 24 weeks in human), WNT/β-catenin signaling regulates the balance of proliferation and differentiation of the distal
epithelium. In the saccular to alveolar stage (E17.5 to postnatal day 5, postnatal day 5 to day 30 in mouse, 24 weeks to 36 weeks, 36 weeks and
after in human), WNT/β-catenin signaling may organize the alveolarization and vascularization and the formation of secondary septa
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Table 1 Summary of developmental WNT/β-catenin signaling, expression pattern, study models, and phenotypes
Expression Study model Phenotype Reference
WNT ligands
WNT2 MS Wnt2 knockout 1. Hypoplastic lungs with relatively normal airway development
2. Reduced proliferation of EP and MS lineage
3. Several signaling pathways and transcription factors for lung
development were reduced
[27]
WNT2b MS Wnt2b knockout Viable and no discernable phenotype [27]
WNT2/2b MS Wnt2/2b double knockout Complete lung agencies [27]
WNT4 MS Wnt4 knockout 1. Lung hypoplasia and tracheal abnormalities
2. Reduced mesodermal proliferation in the lung bud
[30]
WNT5a MS, EP(E12)
Distal and proximal EP (E16)
Cells surrounding distal
and proximal EP (E18)
Wnt5a knockout
Wnt5a-SPC transgenic
1. Larger lungs, foreshortened trachea, overexpansion of distal airways,
thickened intersaccular interstituim (knockout)




WNT7b EP (E12.5 to E16.5) both in
the distal and larger mainstem
bronchial airways
Conditional knockout of Wnt7b in
Sox2-expressed embryo
1. Hypoplastic lungs with normal patterning and cell differentiation




FZDI MS In situ hybridization NA [33]
FZD2 EP (distal) Conditional knockout of Frz2 in
Shh-expressing cells
Formation of cysts in distal airways and defective branching
morphogenesis
[35, 36]
FZD4 MS In situ hybridization NA [33]
FZD7 MS In situ hybridization NA [33]
FZD8 EP In situ hybridization [34]
FZD10 EP (distal) Immunohistochemistry NA [33]
LRP5 EP (upper airway), muscular
component of large vessels
Lrp5 knockout Impairment of alveolar and vascular formation in neonatal lungs
due to the decrease of angiopoietin/Tie2 pathway
[33, 37]
LRP6 EP (upper airway) In situ hybridization NA [33]
Extracellular modulators
DKK-1 EP (distal) In situ hybridization Treatment of E11.5 lung explants by Dkk1 disrupts branching
morphogenesis
[34]




APC MS Conditional knockout of Apc in
Tbx4-expressing mesenchymal cells
APC knockout fetus shows severe lung hemorrhage in E14.5 and
dies in E15.5, with condensed mesenchymal cells around















Table 1 Summary of developmental WNT/β-catenin signaling, expression pattern, study models, and phenotypes (Continued)
β-catenin
β-catenin EP, MS 1. Conditional knockout of β-catenin in
SPC-expressing cells
2. Conditional knockout of β-catenin in
Shh-expressing cells
3. Conditional knockout of β-catenin in
Sox2-expressing cells
4. Conditional knockout of β-catenin in
Demol-expressing mesenchymal cells
1. Multiple, enlarged, and elongated bronchiolar tubes with a lack
of alveolar sacs (β-catenin-SPC knockout)
2. Absence of both trachea and lung due to the defect of Nkx2.1
expression (B-catenin-Shh knockout)
3. Defective bronchiolar epithelial cell differentiation and marked
ectasis of the developing and adult airway (β-catenin-Sox2 knockout)
4. Shortened trachea and reduced branching morphogenesis.
Defect of sub-mesothelial mesenchymal domain containing
Fgf10-expressing progenitors.
[26, 28, 38–40]














and duration of β-catenin expression are important for
proper lung development. Prolonged activation of a β-
catenin-Lef1 fusion protein in distal lung endoderm led to
the development of an undifferentiated distal airway epi-
thelium and resulted in ectopic expression of gene charac-
teristic of intestinal epithelial lineages [26]. Another study
revealed that sustained β-catenin activity within the distal
lung endoderm in early lung development results in the
loss of Sox2, a regulator of developing proximal airway
progenitors, and defective bronchiolar epithelial cell differ-
entiation and marked ectasia of the developing and adult
airway [39]. β-Catenin appears to be an essential mediator
with critical links to its target transcription factors as well
as various signaling pathways associated with lung devel-
opment, such as, FGF [40], BMP4, or N-myc [41]
signaling.
WNT signal antagonists in the developing mouse lung
Activation of WNT signaling is highly controlled by sev-
eral intra- and extracellular proteins. Dickkopf (DKK1-4)
proteins antagonize WNT/β-catenin signaling by bind-
ing to LRP5/6. Dkk-1, 2, and 3 are expressed in distal
lung epithelium from E11.5 (Dkk-2), E12.5 (Dkk-3), and
E13.5 (Dkk-1) onward [36]. WNT/β-catenin signaling
was decreased in distal airways of TOPGAL WNT-
reporter mouse at E14.5 after the onset of Dkk-1 expres-
sion in the distal lung [36]. Furthermore, the DKK-1-
treated lung explants from E11.5 mice showed impaired
branching, failed cleft formation, and enlarged terminal
buds with fibronectin deposition [36]. Retinoic acid (RA)
is a known canonical WNT activator. Using mice with an
RA-deficient lung foregut, it was shown that WNT/β-ca-
tenin signal activation, at the onset of lung specification, is
dependent on the repression of Dkk-1 by endogenous RA
[42], indicating that repression and expression of DKKs
takes part in WNT/β-catenin signaling coordination dur-
ing lung development.
SFRP-1, which antagonizes WNT/β-catenin signaling
by binding extracellular WNT ligands, can also be de-
tected in the distal epithelium and the surrounding mes-
enchyme from E13.5 to 15.5; however, it has not been
observed in the later stages of lung development [43]. In
Sfrp-1 knockout mice, it was shown that nuclear β-
catenin levels were enhanced after E16.5 to E18.5 and
that the alveolar ducts were dilated postnatally com-
pared with the wild-type mice [43], indicating that
SFRP-1 is involved in the coordination of nuclear β-
catenin translocation for proper alveolarization.
APC, a component of the intracellular β-catenin de-
struction complex, is highly expressed in mesenchymal
cells surrounding the large airways at E14.5 lung and
can be detected in both mesenchymal as well as epithe-
lial cells at E18.5 [44]. Lung mesenchyme-specific
conditional Apc knockdown results in hyperactivation of β-
catenin in embryonic lung mesenchyme at E10.5 and fetal
death at E15.5 due to massive pulmonary hemorrhage.
Histological analysis of Apc knockout mice revealed abnor-
mal proliferation and disrupted differentiation of pulmon-
ary mesenchymal cells and inhibition of branching
morphogenesis and vasculogenesis [45].
Taken together, WNT signal components, including
several antagonists, are involved in a variety of critical
processes during murine lung development, including
the onset of lung specification, branching morphogen-
esis, alveolar formation, and angiogenesis with tightly
coordinated epithelial and mesenchymal expression pat-
terns for each time point and developmental stage. As
such, it is reasonable to speculate that perturbation of
WNT signaling on several levels during lung develop-
ment may lead to the arrest of alveolarization and
vascularization as observed clinically in BPD.
In contrast to mouse lung development, our know-
ledge about WNT signaling in human lung development
remains sparse. To date, only two studies exist that re-
ports on WNT signaling expression in developing hu-
man lung. Zhang et al. performed quantitative PCR and
in situ hybridization using a developing human lung and
showed that messenger RNA (mRNA) expression of
WNT2, WNT7B, FZD4, FZD7, LRP5, and LRP6 was re-
stricted to the alveolar and bronchial epithelium in the
human lungs at 7, 12, 17, and 21 weeks of gestation [46].
Most WNT components were up-regulated gradually
until 17 weeks and subsequently decreased in 21 weeks
of gestation [46]. Sharma et al. performed differential
gene expression analysis using human lung tissue sam-
ples across pseudoglandular and canalicular stages of de-
velopment and DNA samples obtained from two cohorts
of childhood bronchial asthma [47]. They showed that
both WIF1 and Wnt1-inducible signaling pathway
protein-1 (WISP1) are associated with intrauterine air-
way development and lung function impairment in
childhood asthmatic patients [47].
Notably, there are several differences between mouse
and human lung development in terms of cellular com-
position, timing of branching morphogenesis, or alveolar
maturation [21, 48]. In the mouse lung, a pseudostrati-
fied epithelial layer including basal cells are only found
in the trachea and main stem bronchus, whereas it is ex-
tended into terminal bronchioles in the human lung. In
addition, club cells are found throughout mouse airways,
while they are only found in the bronchiolar epithelium
in the human lung. The number of the branches in the
bronchial tree is higher in humans compared to mouse
lungs. The lobation or branch pattern also differs be-
tween human and mouse [49]. Alveolar formation
started from saccular stage, E17.5, in mouse, and around
24 weeks, late canalicular stage in human [48]. Consider-
ing these differences, further approaches to decipher the
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role of developmental signaling pathways in human lung
development are required, using, e.g., human histological
samples [50] or human induced pluripotent stem (iPS)
cells [48].
Involvement of WNT signaling in early lung injury and
adult chronic lung diseases
A number of environmental insults during pre- and
postnatal development are known to induce deranged
lung morphogenesis and have also been shown to affect
WNT signaling. Several studies have been conducted to
investigate whether insults to the developing lung by
incidental environmental factors, such as postnatal infec-
tion or maternal cigarette smoke as well as medical
interventions, such as ventilation and oxygen supple-
mentation, affect lung morphogenesis and repair process
via WNT signaling. Neonatal hyperoxia is one of the
widely used animal (mainly rodent) models to mimic
BPD, i.e., causing impaired alveolarization/vascularization
in neonatal lungs [51]. Neonatal hyperoxia following ma-
ternal bacterial infection is another rodent model for BPD
[51, 52]. Since BPD is caused by a variety of factor, includ-
ing hyperoxia exposure, intrauterine infection, high-
pressure ventilation, or prematurity of the lungs, rodent
models of BPD, including hyperoxia exposure, do not
completely recapitulate the BPD observed in clinical set-
tings. However, because the lung samples from human ne-
onates are rare, those rodent models of BPD, including
hyperoxia exposure models focusing especially on alveo-
larization/vascularization, are important tools to reveal
the pathophysiology of new BPD.
These pre- and postnatal insults can result in a variety
of early lung diseases next to BPD. In particular, bron-
chial asthma exhibits a high incidence in childhood and
adolescence. Bronchial asthma is considered to be highly
influenced by maternal smoking [53], diet [54], intra-
uterine growth restriction [55, 56], or exposure to patho-
gens [57, 58]. In this next section, we discuss the
environmental insult-associated with altered WNT/β-ca-
tenin signaling in lung injury occurring during early lung
development and its potential contribution to adult
chronic lung diseases.
Infection and inflammation
Prenatal infections are known to impact lung develop-
ment. Premature rupture of the amniotic membrane re-
sults in increased susceptibility to intrauterine infections.
Antenatal inflammation of chorioamniotic membranes
causes premature birth and adversely affects lung develop-
ment [59]. Intra-amniotic lipopolysaccharide (LPS) expos-
ure, which mimics amniotic bacterial infection, decreases
the expression of Lef-1, Wnt1, Wnt4, and β-catenin in the
canalicular stage of lung development [60]. Similarly, in
adult mice, acute lung injury caused by intra-tracheal
application of LPS and followed by high tidal volume
mechanical ventilation results in the activation of DKK1
and the subsequent down-regulation of active β-catenin in
the lung alveolar epithelium. It was shown that DKK-1 is
released from activated platelets, and the binding affinity
of DKK-1 to alveolar epithelial cells was increased during
acute lung inflammation [61]. Although only a few reports
have shown the relationship between early lung infection/
inflammation and WNT signaling so far, the data to
date are intriguing and further studies investigating
human lungs undergoing prenatal infections, such as
chorioamnionitis-induced neonatal lung injury, will be
important.
Smoking-related injury
Maternal smoking is one of the important risk factors
for chronic lung diseases in children including recurrent
respiratory infection, infantile wheezing, bronchial
asthma, and lower respiratory function in early adult-
hood [53, 62, 63]. It has also been shown that maternal
smoking affects alveolarization/vascularization in devel-
oping lung in vivo [64, 65]. Bronchial asthma shares
some similarities with BPD (e.g., pathologic airways and
the presence of clinical symptoms like wheezing) and
has been associated with aberrant WNT signaling as well
[47, 66]. Impaired lung growth by these and other envir-
onmental factors may cause the formation of smaller
airways and decreased lung capacity contributing to
childhood asthma and lower respiratory function in early
adulthood [67]. In the adult lung, dysfunction of WNT
signaling contributes to the impaired epithelial repair
processes in disease [17, 68]. WNT signaling is reduced
in the lungs from COPD patients, a smoking-related dis-
ease, and the pharmacological activation of the signaling
pathway through GSK3β inhibition activates epithelial
repair properties and attenuates known pathological
features of emphysema ex vivo [68] and in vivo [17, 69].
Recently, Jiang et al. reported that FAM13A, a gene as-
sociated with COPD susceptibility [69], might lead to
emphysema development by facilitating β-catenin deg-
radation [70]. Furthermore, WNT/β-catenin signaling
components, including canonical WNT ligands, FZDs,
signal transducers, and target genes are down-regulated,
while antagonists such as SFRP-1 and DKK-1 are up-
regulated, in human lung tissue [43] and in particular
in the small airway epithelium [71, 72] from COPD
patients.
Much less is known about the effects of maternal
smoking on WNT signaling during lung development.
Maternal smoking during pregnancy has been shown to
decrease Fzd7 and Ctnnb1 (β-catenin) mRNA in neo-
natal Balb/c mice [73]. Furthermore, it was recently re-
ported that protein and mRNA expression of SFRP-1
were significantly up-regulated in the placental tissues in
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smoking women compared with those from non-
smokers [74]. Furthermore, a carbon monoxide analog,
one of the components in cigarettes, increased SFRP-1
expression accompanied by decreased WNT/β-catenin
signaling in a human trophoblast cell line. In addition,
maternal Sfrp-1 overexpression causes fetal growth re-
striction in mice [74]. Altogether, these studies strongly
suggest that (maternal) smoking and components of
cigarette smoke significantly impact WNT signaling ac-
tivity. However, cigarette smoking is also known to gen-
erally inhibit fetal growth and thus it remains an open
question whether maternal smoking/nicotine exposure
directly increases extracellular modulators of WNT and
decreases WNT/β-catenin signaling in the lung to affect
fetal lung development or whether maternal smoking/
nicotine exposure induces fetal growth restriction to
cause premature birth and subsequent BPD.
Given these studies, it is plausible that chronic lung
diseases, such as COPD, develop as a result of early lung
insults leading to aberrant WNT/β-catenin signaling and
thus lung repair capacity. A gradual decline in lung
function in early adulthood might be due to aberrant
WNT/β-catenin signaling, which is retained over time,
eventually resulting in adult chronic lung diseases. Gen-
eration of experimental models to follow this hypothesis
and long-term follow-up studies of new BPD patients
are needed. In particular, emerging evidences suggest
that epigenetic alterations, i.e., modified gene expression
via DNA methylation, histone modification, or micro-
RNA, of WNT signaling represents an important area of
investigation. Recently, it has been shown that cigarette
smoke exposure epigenetically altered WNT/β-catenin
signaling in lung cancer cells by histone modification or
microRNA expression [75–77]. In the developing lung,
differential methylation of WNT/β-catenin signal genes
have been reported in neonatal and adult mouse lungs
[78]. Although there is no study addressing epigenetic
alterations of WNT signaling by cigarette smoke expos-
ure in the developing lung, it is reported that psycho-
logical stress during pregnancy caused altered DNA
methylation of non-canonical, WNT5a/Ca2+ pathway
and postnatal wheeze of the affected children [66]. As
such, further investigations on how environmental fac-
tors, including maternal smoking, alter WNT signaling
by epigenetic modifications and thus affect lung develop-
ment of the neonate will be important.
WNT/β-catenin and TGF-β signaling in new BPD
In addition to WNT/β-catenin, transforming growth fac-
tor (TGF)-β signaling is a critical pathway for lung de-
velopment [21]. It has been shown that TGF-β is an
important mediator for the development of BPD [79–81]
and is activated in neonatal rat lungs after hyperoxia ex-
posure [82] as well as in neonatal mouse lungs after
mechanical ventilation with mild hyperoxia [83]. There
are also reports regarding the dual activation of WNT/
β-catenin and TGF-β signaling in hyperoxia exposure
models, but the crosstalk between the two pathways is
incompletely understood [82, 84]. Active WNT/β-ca-
tenin signaling has been reported in fibrotic adult lung
diseases, such as IPF [14–16], in which TGF-β signaling
is highly involved in epithelial cell reprogramming and
myofibroblast activation [85]. Furthermore, TGF-β re-
sults in enhanced expression of WNT ligands and
activation of β-catenin in vitro [86]. TGF-β-induced acti-
vation of WNT/β-catenin signaling [87, 88] may also
play a key role during developing BPD as well as adult fi-
brotic lung diseases, including IPF.
WNT signaling in BPD
To date, only a few studies addressed WNT signaling in
new BPD patients. In the lungs of patients who died
from BPD, nuclear β-catenin, which is used as a surro-
gate marker for WNT/β-catenin activity, along with
phosphorylated (inactivated) GSK-3β was found in the
thickened alveolar septa [89, 90]. Notably, whole exome
sequencing using blood spots from twin neonate pairs
with and without BPD revealed that genes associated
with WNT/β-catenin signaling were up-regulated in
BPD [91].
Nuclear translocation of β-catenin and increased Lef1
expression was observed in the lung from neonatal rats
exposed to hyperoxia (95 % oxygen) in the alveolar stage
(postnatal days 0 to 7) [82]. Moreover, it has been shown
that neonatal hyperoxia increased nuclear β-catenin and
decreased alveolar epithelial type II (ATII) cell to ATI
cell transdifferentiation [84, 92], which is generally
considered as a repair process of alveolar epithelial cells
following injury. Furthermore, hyperoxia-induced inhib-
ition of ATII to ATI transdifferentiation was recovered
by small interfering RNA (siRNA)-mediated knockdown
of Wnt3a in vitro [92]. However, it has been reported
that in the adult mouse lung, β-catenin was induced
during ATII cell to ATI cell transdifferentiation in nor-
moxia condition [93, 94]. This discrepancy might be due
to hyperoxia condition or using neonatal lung in the
former studies. Further studies are needed to clarify this
issue. Another study showed the enhancement of WNT/
β-catenin signaling in impaired vascularization [95].
Taken together, canonical WNT/β-catenin signaling is
activated in lung samples from BPD patients and neo-
natal rodent model of hyperoxia exposure in the lung.
This activation of WNT signaling might be a result of
“attempted (and failed)” regeneration after injury of al-
veolar epithelial cells, which is a hypothesized processes
model in IPF lungs [11].
It is unclear whether BPD contributes to the onset of
adult chronic lung diseases, such as COPD or IPF. In
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adult chronic lung diseases, canonical WNT/β-catenin
signaling is down-regulated in emphysematous lungs
[17] while up-regulated in fibrotic lungs [15]. In BPD
lungs, as mentioned above, enhanced expression of
TGF-β [79] and/or WNT/β-catenin signaling was ob-
served [89, 90]. In contrast, intrauterine infection or
cigarette smoke decreased WNT/β-catenin signaling.
Longitudinal studies showed that along with decreased
FEV1, a hallmark of obstructive lung diseases, forced
vital capacity (FVC), a hallmark of restrictive lung
diseases, was also lower in BPD survivors [96, 97]. Al-
though characterizing a disease entity as either emphy-
sema or fibrosis is oversimplification, it seems like BPD
features a co-existence of emphysema and fibrosis as
reported [98, 99]. It is possible that different environmental
insults at different time points during lung development
might cause different expression patterns of WNT signal-
ing. Also, if new BPD survivors with impaired alveolariza-
tion/vascularization are exposed to a “second hit,” such as
cigarette smoke, pathogens, or hyperoxia, at a later time
point, they might develop adult chronic lung diseases with
aberrant (increased/decreased) WNT signaling. Longitu-
dinal studies are needed to study whether BPD survivors
are more susceptible to developing adult chronic lung dis-
eases. Establishing animal models to mimic BPD and follow
the outcome of the developing lung is needed.
Clinical implications and limitations of WNT/β-catenin
signaling in lung development
Several studies indicated that targeting WNT/β-catenin
signaling may be a therapeutic strategy in BPD. Vitamin
A, whose metabolite is RA, has been used to prevent
BPD progression [100–102] although the effect is still
controversial. As mentioned previously, RA activated
WNT/β-catenin signaling via inhibition of DKK-1 [42].
In this context, active WNT/β-catenin signaling might
be beneficial for arrested alveolarization, as it has been
reported to maintain alveolar stem/progenitor cell popu-
lations [11, 103], such as ATII cells [94].
On the other hand, it is reported that intraperitoneal
administration of Mesd, a specialized chaperone for
LRP5/6 to inhibit WNT/β-catenin signaling, attenuated
hyperoxia-induced pulmonary hypertension and right
ventricular hypertrophy in neonatal rats [95]. Another
study showed that ICG-001, a small molecule which in-
hibits WNT/β-catenin signaling via interaction between
β-catenin and CREB-binding protein (CBP), an intrinsic
histone acetyltransferase to activate gene transcription,
increased alveolarization and decreased vascular remod-
eling to develop pulmonary hypertension [104]. Resvera-
trol, a polyphenol found in several fruits and nuts, was
also shown to attenuate hyperoxia-induced model of
BPD in neonatal rats [64, 84]. It is important to address
the question when or where WNT/β-catenin signaling
should be inactivated/activated for physiologic lung de-
velopment and perinatal lung injury/repair processes.
Thus, it is worth exploring whether the attenuation of
alveolar repair process or epigenetic modification alter-
ing WNT signaling will be candidates for clinical
implications.
However, as most of the data shown here originate
from rodent experiments, limitations for translation of
the findings have to be considered. Given the difficulty
of obtaining human neonatal lung tissue for analysis, re-
cent approaches using 3D lung tissue cultures [68] or
iPS cells [105, 106] from BPD patients represent promis-
ing tools to further explore signaling pathways involved
in the pathogenesis of disease, such as WNT/β-catenin
signaling. Collecting more evidence from preterm in-
fants will be needed to identify new therapeutic targets
in WNT/β-catenin signaling pathway.
Conclusions
Here, we discussed the potential role of the developmen-
tal WNT signaling pathway as a potential missing link
between early impairment of lung development and the
outcome in the adult lung. First, WNT/β-catenin signal-
ing is essential for lung development in utero, which has
been elegantly investigated using the advantage of sev-
eral wild-type and transgenic animals. Second, growing
data suggest that WNT/β-catenin signaling is involved
in pre- and postnatal lung injury and repair process; and
third, several lines of evidence exists that highlight the
impact of impaired WNT/β-catenin signaling on the de-
velopment of adult chronic lung diseases, which seems
similar to lung injury-repair processes in the developing
lung. Additional studies are needed to advance our
current knowledge of the pathogenesis of perinatal lung
diseases, such as BPD, to shed further light into signal-
ing pathways involved that ultimately might lead to
novel therapeutic options for lung injury-repair process
or epigenetic modifications in WNT signaling.
Funding
This work is supported by a postdoctoral research fellowship from the European
Respiratory Society (Ota C, LTRF-2015-4822, Baarsma HA, LTRF-79-2012)
and Helmholtz Postdoctoral Programme (Baarsma HA, PD-135), a Whitaker
International Scholar Fellowship, and the Helmholtz Munich Postdoctoral
Programme (Wagner DE).
Authors’ contributions
OC drafted the manuscript and contributed to the conception and the
design and the acquisition of the data. BHA, WDE, HA, KM contributed to the
acquisition of the data and revised the manuscript critically for important
intellectual content. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1Comprehensive Pneumology Center, Helmholtz Center Munich,
Ludwig-Maximilians-University, University Hospital Grosshadern, German
Ota et al. Molecular and Cellular Pediatrics  (2016) 3:34 Page 10 of 13
Center of Lung Research (DZL), Munich, Germany. 2The Perinatal Center,
Campus Grosshadern, Ludwig-Maximilians-University, Munich, Germany.
Received: 10 March 2016 Accepted: 25 September 2016
References
1. Northway WH Jr, Rosan RC, Porter DY (1967) Pulmonary disease following
respirator therapy of hyaline-membrane disease. Bronchopulmonary
dysplasia. N Engl J Med 276(7):357–368. doi:10.1056/NEJM196702162760701
2. Baraldi E, Filippone M (2007) Chronic lung disease after premature birth. N
Engl J Med 357(19):1946–1955. doi:10.1056/NEJMra067279
3. Madurga A, Mizikova I, Ruiz-Camp J, Morty RE (2013) Recent advances in
late lung development and the pathogenesis of bronchopulmonary
dysplasia. American journal of physiology Lung cellular and molecular
physiology 305(12):L893–L905. doi:10.1152/ajplung.00267.2013
4. Vollsaeter M, Roksund OD, Eide GE, Markestad T, Halvorsen T (2013) Lung
function after preterm birth: development from mid-childhood to
adulthood. Thorax 68(8):767–776. doi:10.1136/thoraxjnl-2012-202980
5. Ronkainen E, Dunder T, Peltoniemi O, Kaukola T, Marttila R, Hallman M
(2015) New BPD predicts lung function at school age: follow-up study and
meta-analysis. Pediatr Pulmonol 50(11):1090–1098. doi:10.1002/ppul.23153
6. Gibson AM, Reddington C, McBride L, Callanan C, Robertson C, Doyle LW
(2015) Lung function in adult survivors of very low birth weight, with and
without bronchopulmonary dysplasia. Pediatr Pulmonol 50(10):987–994. doi:
10.1002/ppul.23093
7. Stocks J, Hislop A, Sonnappa S (2013) Early lung development: lifelong
effect on respiratory health and disease. Lancet Respir Med 1(9):728–742.
doi:10.1016/S2213-2600(13)70118-8
8. Harding R, Maritz G (2012) Maternal and fetal origins of lung disease in
adulthood. Seminars in fetal & neonatal medicine 17(2):67–72. doi:10.1016/j.
siny.2012.01.005
9. Kranenburg AR, De Boer WI, Van Krieken JH, Mooi WJ, Walters JE, Saxena PR,
Sterk PJ, Sharma HS (2002) Enhanced expression of fibroblast growth factors
and receptor FGFR-1 during vascular remodeling in chronic obstructive
pulmonary disease. Am J Respir Cell Mol Biol 27(5):517–525. doi:10.1165/
rcmb.4474
10. Morino S, Nakamura T, Toba T, Takahashi M, Kushibiki T, Tabata Y, Shimizu Y
(2005) Fibroblast growth factor-2 induces recovery of pulmonary blood flow in
canine emphysema models. Chest 128(2):920–926. doi:10.1378/chest.128.2.920
11. Konigshoff M, Eickelberg O (2010) WNT signaling in lung disease: a failure or
a regeneration signal? Am J Respir Cell Mol Biol 42(1):21–31. doi:10.1165/
rcmb.2008-0485TR
12. Myllarniemi M, Lindholm P, Ryynanen MJ, Kliment CR, Salmenkivi K, Keski-
Oja J, Kinnula VL, Oury TD, Koli K (2008) Gremlin-mediated decrease in bone
morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir
Crit Care Med 177(3):321–329. doi:10.1164/rccm.200706-945OC
13. Beers MF, Morrisey EE (2011) The three R’s of lung health and disease:
repair, remodeling, and regeneration. J Clin Invest 121(6):2065–2073.
doi:10.1172/JCI45961
14. Chilosi M, Poletti V, Zamo A, Lestani M, Montagna L, Piccoli P, Pedron S,
Bertaso M, Scarpa A, Murer B, Cancellieri A, Maestro R, Semenzato G,
Doglioni C (2003) Aberrant Wnt/beta-catenin pathway activation in
idiopathic pulmonary fibrosis. Am J Pathol 162(5):1495–1502
15. Konigshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F,
Fink L, Seeger W, Schaefer L, Gunther A, Eickelberg O (2009) WNT1-
inducible signaling protein-1 mediates pulmonary fibrosis in mice and is
upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest
119(4):772–787. doi:10.1172/JCI33950
16. Konigshoff M, Balsara N, Pfaff EM, Kramer M, Chrobak I, Seeger W, Eickelberg
O (2008) Functional Wnt signaling is increased in idiopathic pulmonary
fibrosis. PLoS One 3(5):e2142. doi:10.1371/journal.pone.0002142
17. Kneidinger N, Yildirim AO, Callegari J, Takenaka S, Stein MM, Dumitrascu R,
Bohla A, Bracke KR, Morty RE, Brusselle GG, Schermuly RT, Eickelberg O,
Konigshoff M (2011) Activation of the WNT/beta-catenin pathway
attenuates experimental emphysema. Am J Respir Crit Care Med 183(6):
723–733. doi:10.1164/rccm.200910-1560OC
18. Krauss-Etschmann S, Bush A, Bellusci S, Brusselle GG, Dahlen SE, Dehmel S,
Eickelberg O, Gibson G, Hylkema MN, Knaus P, Konigshoff M, Lloyd CM,
Macciarini P, Mailleux A, Marsland BJ, Postma DS, Roberts G, Samakovlis C,
Stocks J, Vandesompele J, Wjst M, Holloway J (2013) Of flies, mice and men:
a systematic approach to understanding the early life origins of chronic
lung disease. Thorax 68(4):380–384. doi:10.1136/thoraxjnl-2012-201902
19. Baarsma HA, Konigshoff M, Gosens R (2013) The WNT signaling pathway
from ligand secretion to gene transcription: molecular mechanisms and
pharmacological targets. Pharmacol Ther 138(1):66–83. doi:10.1016/j.
pharmthera.2013.01.002
20. Volckaert T, De Langhe SP (2015) Wnt and FGF mediated epithelial-
mesenchymal crosstalk during lung development. Dev Dyn 244(3):342–366.
doi:10.1002/dvdy.24234
21. Morrisey EE, Hogan BL (2010) Preparing for the first breath: genetic and
cellular mechanisms in lung development. Dev Cell 18(1):8–23. doi:10.1016/j.
devcel.2009.12.010
22. Tebar M, Destree O, de Vree WJ, Ten Have-Opbroek AA (2001) Expression of
Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse
lung. Mech Dev 109(2):437–440
23. De Langhe SP, Carraro G, Tefft D, Li C, Xu X, Chai Y, Minoo P,
Hajihosseini MK, Drouin J, Kaartinen V, Bellusci S (2008) Formation
and differentiation of multiple mesenchymal lineages during lung
development is regulated by beta-catenin signaling. PLoS One
3(1):e1516. doi:10.1371/journal.pone.0001516
24. Al Alam D, Green M, Tabatabai Irani R, Parsa S, Danopoulos S, Sala FG, Branch J,
El Agha E, Tiozzo C, Voswinckel R, Jesudason EC, Warburton D, Bellusci S (2011)
Contrasting expression of canonical Wnt signaling reporters TOPGAL, BATGAL
and Axin2(LacZ) during murine lung development and repair. PLoS One 6(8):
e23139. doi:10.1371/journal.pone.0023139
25. van Amerongen R, Berns A (2006) Knockout mouse models to study Wnt
signal transduction. Trends Genet 22(12):678–689. doi:10.1016/j.tig.2006.10.001
26. Okubo T, Hogan BL (2004) Hyperactive Wnt signaling changes the
developmental potential of embryonic lung endoderm. J Biol 3(3):11.
doi:10.1186/jbiol3
27. Goss AM, Tian Y, Tsukiyama T, Cohen ED, Zhou D, Lu MM, Yamaguchi TP,
Morrisey EE (2009) Wnt2/2b and beta-catenin signaling are necessary and
sufficient to specify lung progenitors in the foregut. Dev Cell 17(2):290–298.
doi:10.1016/j.devcel.2009.06.005
28. Mucenski ML, Wert SE, Nation JM, Loudy DE, Huelsken J, Birchmeier W,
Morrisey EE, Whitsett JA (2003) beta-Catenin is required for specification of
proximal/distal cell fate during lung morphogenesis. J Biol Chem 278(41):
40231–40238. doi:10.1074/jbc.M305892200
29. Rajagopal J, Carroll TJ, Guseh JS, Bores SA, Blank LJ, Anderson WJ, Yu J,
Zhou Q, McMahon AP, Melton DA (2008) Wnt7b stimulates embryonic lung
growth by coordinately increasing the replication of epithelium and
mesenchyme. Development 135(9):1625–1634. doi:10.1242/dev.015495
30. Caprioli A, Villasenor A, Wylie LA, Braitsch C, Marty-Santos L, Barry D, Karner
CM, Fu S, Meadows SM, Carroll TJ, Cleaver O (2015) Wnt4 is essential to
normal mammalian lung development. Dev Biol 406(2):222–234. doi:10.
1016/j.ydbio.2015.08.017
31. Li C, Xiao J, Hormi K, Borok Z, Minoo P (2002) Wnt5a participates in distal
lung morphogenesis. Dev Biol 248(1):68–81
32. Li C, Hu L, Xiao J, Chen H, Li JT, Bellusci S, Delanghe S, Minoo P (2005)
Wnt5a regulates Shh and Fgf10 signaling during lung development. Dev
Biol 287(1):86–97. doi:10.1016/j.ydbio.2005.08.035
33. Wang Z, Shu W, Lu MM, Morrisey EE (2005) Wnt7b activates canonical
signaling in epithelial and vascular smooth muscle cells through
interactions with Fzd1, Fzd10, and LRP5. Mol Cell Biol 25(12):5022–5030. doi:
10.1128/MCB.25.12.5022-5030.2005
34. Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K,
Yang J, DeMayo FJ, Whitsett JA, Parmacek MS, Morrisey EE (2008) A Gata6-
Wnt pathway required for epithelial stem cell development and airway
regeneration. Nat Genet 40(7):862–870. doi:10.1038/ng.157
35. Kadzik RS, Cohen ED, Morley MP, Stewart KM, Lu MM, Morrisey EE (2014)
Wnt ligand/Frizzled 2 receptor signaling regulates tube shape and branch-
point formation in the lung through control of epithelial cell shape. Proc
Natl Acad Sci U S A 111(34):12444–12449. doi:10.1073/pnas.1406639111
36. De Langhe SP, Sala FG, Del Moral PM, Fairbanks TJ, Yamada KM, Warburton
D, Burns RC, Bellusci S (2005) Dickkopf-1 (DKK1) reveals that fibronectin is a
major target of Wnt signaling in branching morphogenesis of the mouse
embryonic lung. Dev Biol 277(2):316–331. doi:10.1016/j.ydbio.2004.09.023
37. Mammoto T, Chen J, Jiang E, Jiang A, Smith LE, Ingber DE, Mammoto A
(2012) LRP5 regulates development of lung microvessels and alveoli
through the angiopoietin-Tie2 pathway. PLoS One 7(7):e41596. doi:10.1371/
journal.pone.0041596
Ota et al. Molecular and Cellular Pediatrics  (2016) 3:34 Page 11 of 13
38. Harris-Johnson KS, Domyan ET, Vezina CM, Sun X (2009) beta-Catenin
promotes respiratory progenitor identity in mouse foregut. Proc Natl Acad
Sci U S A 106(38):16287–16292. doi:10.1073/pnas.0902274106
39. Hashimoto S, Chen H, Que J, Brockway BL, Drake JA, Snyder JC, Randell SH,
Stripp BR (2012) beta-Catenin-SOX2 signaling regulates the fate of developing
airway epithelium. J Cell Sci 125(Pt 4):932–942. doi:10.1242/jcs.092734
40. Cohen ED, Wang Z, Lepore JJ, Lu MM, Taketo MM, Epstein DJ, Morrisey EE
(2007) Wnt/beta-catenin signaling promotes expansion of Isl-1-positive
cardiac progenitor cells through regulation of FGF signaling. J Clin Invest
117(7):1794–1804. doi:10.1172/JCI31731
41. Shu W, Guttentag S, Wang Z, Andl T, Ballard P, Lu MM, Piccolo S,
Birchmeier W, Whitsett JA, Millar SE, Morrisey EE (2005) Wnt/beta-
catenin signaling acts upstream of N-myc, BMP4, and FGF signaling
to regulate proximal-distal patterning in the lung. Dev Biol 283(1):
226–239. doi:10.1016/j.ydbio.2005.04.014
42. Chen F, Cao Y, Qian J, Shao F, Niederreither K, Cardoso WV (2010) A retinoic
acid-dependent network in the foregut controls formation of the mouse
lung primordium. J Clin Invest 120(6):2040–2048. doi:10.1172/JCI40253
43. Foronjy R, Imai K, Shiomi T, Mercer B, Sklepkiewicz P, Thankachen J, Bodine
P, D’Armiento J (2010) The divergent roles of secreted frizzled related
protein-1 (SFRP1) in lung morphogenesis and emphysema. Am J Pathol
177(2):598–607. doi:10.2353/ajpath.2010.090803
44. Li A, Xing Y, Chan B, Heisterkamp N, Groffen J, Borok Z, Minoo P, Li C (2010) Cell
type-specific expression of adenomatous polyposis coli in lung development,
injury, and repair. Dev Dyn 239(8):2288–2297. doi:10.1002/dvdy.22364
45. Luo Y, El Agha E, Turcatel G, Chen H, Chiu J, Warburton D, Bellusci S, Qian
BP, Menke DB, Shi W (2015) Mesenchymal adenomatous polyposis coli
plays critical and diverse roles in regulating lung development. BMC Biol 13:
42. doi:10.1186/s12915-015-0153-1
46. Zhang M, Shi J, Huang Y, Lai L (2012) Expression of canonical WNT/beta-
CATENIN signaling components in the developing human lung. BMC Dev
Biol 12:21. doi:10.1186/1471-213X-12-21
47. Sharma S, Tantisira K, Carey V, Murphy AJ, Lasky-Su J, Celedon JC, Lazarus R,
Klanderman B, Rogers A, Soto-Quiros M, Avila L, Mariani T, Gaedigk R,
Leeder S, Torday J, Warburton D, Raby B, Weiss ST (2010) A role for Wnt
signaling genes in the pathogenesis of impaired lung function in asthma.
Am J Respir Crit Care Med 181(4):328–336. doi:10.1164/rccm.200907-1009OC
48. Snoeck HW (2015) Modeling human lung development and disease using
pluripotent stem cells. Development 142(1):13–16. doi:10.1242/dev.115469
49. Metzger RJ, Klein OD, Martin GR, Krasnow MA (2008) The branching
programme of mouse lung development. Nature 453(7196):745–750.
doi:10.1038/nature07005
50. Suzuki T, Suzuki S, Fujino N, Ota C, Yamada M, Suzuki T, Yamaya M, Kondo
T, Kubo H (2014) c-Kit immunoexpression delineates a putative endothelial
progenitor cell population in developing human lungs. American journal of
physiology Lung cellular and molecular physiology 306(9):L855–L865. doi:10.
1152/ajplung.00211.2013
51. Berger J, Bhandari V (2014) Animal models of bronchopulmonary dysplasia.
The term mouse models. American journal of physiology Lung cellular and
molecular physiology 307(12):L936–L947. doi:10.1152/ajplung.00159.2014
52. Velten M, Heyob KM, Rogers LK, Welty SE (2010) Deficits in lung
alveolarization and function after systemic maternal inflammation and
neonatal hyperoxia exposure. J Appl Physiol 108(5):1347–1356. doi:10.1152/
japplphysiol.01392.2009
53. den Dekker HT, Sonnenschein-van der Voort AM, de Jongste JC, Reiss IK,
Hofman A, Jaddoe VW, Duijts L (2015) Tobacco smoke exposure, airway
resistance, and asthma in school-age children: the generation R study.
Chest 148(3):607–617. doi:10.1378/chest.14-1520
54. Thorburn AN, McKenzie CI, Shen S, Stanley D, Macia L, Mason LJ, Roberts LK,
Wong CH, Shim R, Robert R, Chevalier N, Tan JK, Marino E, Moore RJ, Wong
L, McConville MJ, Tull DL, Wood LG, Murphy VE, Mattes J, Gibson PG,
Mackay CR (2015) Evidence that asthma is a developmental origin disease
influenced by maternal diet and bacterial metabolites. Nat Commun 6:7320.
doi:10.1038/ncomms8320
55. Tedner SG, Ortqvist AK, Almqvist C (2012) Fetal growth and risk of
childhood asthma and allergic disease. Clinical and experimental allergy:
journal of the British Society for Allergy and Clinical Immunology 42(10):
1430–1447. doi:10.1111/j.1365-2222.2012.03997.x
56. Mu M, Ye S, Bai MJ, Liu GL, Tong Y, Wang SF, Sheng J (2014) Birth weight
and subsequent risk of asthma: a systematic review and meta-analysis.
Heart, lung & circulation 23(6):511–519. doi:10.1016/j.hlc.2013.11.018
57. Duijts L (2012) Fetal and infant origins of asthma. Eur J Epidemiol
27(1):5–14. doi:10.1007/s10654-012-9657-y
58. Beasley R, Semprini A, Mitchell EA (2015) Risk factors for asthma: is
prevention possible? Lancet 386(9998):1075–1085. doi:10.1016/S0140-
6736(15)00156-7
59. Goldenberg RL, Hauth JC, Andrews WW (2000) Intrauterine infection and
preterm delivery. N Engl J Med 342(20):1500–1507. doi:10.1056/
NEJM200005183422007
60. Kuypers E, Willems MG, Collins JJ, Wolfs TG, Nitsos I, Jane Pillow J, Polglase
GR, Kemp MW, Newnham JP, Delhaas T, Jobe AH, Kallapur SG, Kramer BW
(2014) Altered canonical Wingless-Int signaling in the ovine fetal lung after
exposure to intra-amniotic lipopolysaccharide and antenatal
betamethasone. Pediatr Res 75(2):281–287. doi:10.1038/pr.2013.226
61. Guo Y, Mishra A, Howland E, Zhao C, Shukla D, Weng T, Liu L (2015)
Platelet-derived Wnt antagonist Dickkopf-1 is implicated in ICAM-1/VCAM-1-
mediated neutrophilic acute lung inflammation. Blood 126(19):2220–2229.
doi:10.1182/blood-2015-02-622233
62. Strachan DP, Cook DG (1998) Health effects of passive smoking. 6. Parental
smoking and childhood asthma: longitudinal and case-control studies.
Thorax 53(3):204–212
63. Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, de Marco R,
Norback D, Raherison C, Villani S, Wjst M, Svanes K, Anto JM (2010) Early life
origins of chronic obstructive pulmonary disease. Thorax 65(1):14–20. doi:10.
1136/thx.2008.112136
64. Ozdemir OM, Gozkeser E, Bir F, Yenisey C (2014) The effects of resveratrol
on hyperoxia-induced lung injury in neonatal rats. Pediatrics and
neonatology 55(5):352–357. doi:10.1016/j.pedneo.2013.11.004
65. Manoli SE, Smith LA, Vyhlidal CA, An CH, Porrata Y, Cardoso WV, Baron RM,
Haley KJ (2012) Maternal smoking and the retinoid pathway in the
developing lung. Respir Res 13:42. doi:10.1186/1465-9921-13-42
66. Trump S, Bieg M, Gu Z, Thurmann L, Bauer T, Bauer M, Ishaque N, Roder S,
Gu L, Herberth G, Lawerenz C, Borte M, Schlesner M, Plass C, Diessl N,
Eszlinger M, Mucke O, Elvers HD, Wissenbach DK, von Bergen M, Herrmann
C, Weichenhan D, Wright RJ, Lehmann I, Eils R (2016) Prenatal maternal
stress and wheeze in children: novel insights into epigenetic regulation.
Scientific reports 6:28616. doi:10.1038/srep28616
67. Canoy D, Pekkanen J, Elliott P, Pouta A, Laitinen J, Hartikainen AL, Zitting P,
Patel S, Little MP, Jarvelin MR (2007) Early growth and adult respiratory
function in men and women followed from the fetal period to adulthood.
Thorax 62(5):396–402. doi:10.1136/thx.2006.066241
68. Uhl FE, Vierkotten S, Wagner DE, Burgstaller G, Costa R, Koch I, Lindner M,
Meiners S, Eickelberg O, Konigshoff M (2015) Preclinical validation and
imaging of Wnt-induced repair in human 3D lung tissue cultures. Eur Respir
J 46(4):1150–1166. doi:10.1183/09031936.00183214
69. Wang B, Liang B, Yang J, Xiao J, Ma C, Xu S, Lei J, Xu X, Liao Z, Liu H, Ou X,
Feng Y (2013) Association of FAM13A polymorphisms with COPD and
COPD-related phenotypes in Han Chinese. Clin Biochem 46(16-17):1683–
1688. doi:10.1016/j.clinbiochem.2013.07.013
70. Jiang Z, Lao T, Qiu W, Polverino F, Gupta K, Guo F, Mancini JD, Naing ZZ,
Cho MH, Castaldi PJ, Sun Y, Yu J, Laucho-Contreras ME, Kobzik L, Raby BA,
Choi AM, Perrella MA, Owen CA, Silverman EK, Zhou X (2016) A chronic
obstructive pulmonary disease susceptibility gene, FAM13A, regulates
protein stability of beta-catenin. Am J Respir Crit Care Med. doi: 10.1164/
rccm.201505-0999OC
71. Heijink IH, de Bruin HG, van den Berge M, Bennink LJ, Brandenburg SM, Gosens
R, van Oosterhout AJ, Postma DS (2013) Role of aberrant WNT signalling in the
airway epithelial response to cigarette smoke in chronic obstructive pulmonary
disease. Thorax 68(8):709–716. doi:10.1136/thoraxjnl-2012-201667
72. Wang R, Ahmed J, Wang G, Hassan I, Strulovici-Barel Y, Hackett NR, Crystal
RG (2011) Down-regulation of the canonical Wnt beta-catenin pathway in
the airway epithelium of healthy smokers and smokers with COPD. PLoS
One 6(4):e14793. doi:10.1371/journal.pone.0014793
73. Blacquiere MJ, Timens W, van den Berg A, Geerlings M, Postma DS, Hylkema
MN (2010) Maternal smoking during pregnancy decreases Wnt signalling in
neonatal mice. Thorax 65(6):553–554. doi:10.1136/thx.2009.120154
74. Wang A, Zsengeller ZK, Hecht JL, Buccafusca R, Burke SD, Rajakumar A,
Weingart E, Yu PB, Salahuddin S, Karumanchi SA (2015) Excess placental
secreted frizzled-related protein 1 in maternal smokers impairs fetal growth.
J Clin Invest 125(11):4021–4025. doi:10.1172/JCI80457
75. Hussain M, Rao M, Humphries AE, Hong JA, Liu F, Yang M, Caragacianu D,
Schrump DS (2009) Tobacco smoke induces polycomb-mediated repression
Ota et al. Molecular and Cellular Pediatrics  (2016) 3:34 Page 12 of 13
of Dickkopf-1 in lung cancer cells. Cancer Res 69(8):3570–3578. doi:10.1158/
0008-5472.CAN-08-2807
76. Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, Davis S, Zhang Y,
Hussain M, Xi S, Rao M, Meltzer PA, Schrump DS (2010) Epigenomic alterations
and gene expression profiles in respiratory epithelia exposed to cigarette
smoke condensate. Oncogene 29(25):3650–3664. doi:10.1038/onc.2010.129
77. Xi S, Xu H, Shan J, Tao Y, Hong JA, Inchauste S, Zhang M, Kunst TF,
Mercedes L, Schrump DS (2013) Cigarette smoke mediates epigenetic
repression of miR-487b during pulmonary carcinogenesis. J Clin Invest
123(3):1241–1261. doi:10.1172/JCI61271
78. Cuna A, Halloran B, Faye-Petersen O, Kelly D, Crossman DK, Cui X, Pandit K,
Kaminski N, Bhattacharya S, Ahmad A, Mariani TJ, Ambalavanan N (2015)
Alterations in gene expression and DNA methylation during murine and
human lung alveolar septation. Am J Respir Cell Mol Biol 53(1):60–73. doi:10.
1165/rcmb.2014-0160OC
79. Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, Warburton D (2003)
Transfer of the active form of transforming growth factor-beta 1 gene to
newborn rat lung induces changes consistent with bronchopulmonary
dysplasia. Am J Pathol 163(6):2575–2584
80. Ahlfeld SK, Wang J, Gao Y, Snider P, Conway SJ (2016) Initial suppression of
transforming growth factor-beta signaling and loss of TGFBI causes early
alveolar structural defects resulting in bronchopulmonary dysplasia. Am J
Pathol 186(4):777–793. doi:10.1016/j.ajpath.2015.11.024
81. Morty RE, Konigshoff M, Eickelberg O (2009) Transforming growth factor-
beta signaling across ages: from distorted lung development to chronic
obstructive pulmonary disease. Proc Am Thorac Soc 6(7):607–613. doi:10.
1513/pats.200908-087RM
82. Dasgupta C, Sakurai R, Wang Y, Guo P, Ambalavanan N, Torday JS, Rehan VK
(2009) Hyperoxia-induced neonatal rat lung injury involves activation of
TGF-{beta} and Wnt signaling and is protected by rosiglitazone. American
journal of physiology Lung cellular and molecular physiology 296(6):L1031–
L1041. doi:10.1152/ajplung.90392.2008
83. Hilgendorff A, Parai K, Ertsey R, Jain N, Navarro EF, Peterson JL,
Tamosiuniene R, Nicolls MR, Starcher BC, Rabinovitch M, Bland RD (2011)
Inhibiting lung elastase activity enables lung growth in mechanically
ventilated newborn mice. Am J Respir Crit Care Med 184(5):537–546. doi:10.
1164/rccm.201012-2010OC
84. Xu W, Zhao Y, Zhang B, Xu B, Yang Y, Wang Y, Liu C (2015) Resveratrol
attenuates hyperoxia-induced oxidative stress, inflammation and fibrosis
and suppresses Wnt/beta-catenin signalling in lungs of neonatal rats. Clin
Exp Pharmacol Physiol 42(10):1075–1083. doi:10.1111/1440-1681.12459
85. Fernandez IE, Eickelberg O (2012) New cellular and molecular mechanisms
of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet
380(9842):680–688. doi:10.1016/S0140-6736(12)61144-1
86. Baarsma HA, Engelbertink LH, van Hees LJ, Menzen MH, Meurs H, Timens W,
Postma DS, Kerstjens HA, Gosens R (2013) Glycogen synthase kinase-3 (GSK-
3) regulates TGF-beta(1)-induced differentiation of pulmonary fibroblasts. Br
J Pharmacol 169(3):590–603. doi:10.1111/bph.12098
87. Spanjer AI, Baarsma HA, Oostenbrink LM, Jansen SR, Kuipers CC, Lindner M,
Postma DS, Meurs H, Heijink IH, Gosens R, Konigshoff M (2016) TGF-beta-
induced profibrotic signaling is regulated in part by the WNT receptor
Frizzled-8. FASEB journal: official publication of the Federation of American
Societies for Experimental Biology 30(5):1823–1835. doi:10.1096/fj.201500129
88. Zhou Q, Chen T, Bozkanat M, Ibe JC, Christman JW, Raj JU, Zhou G (2014)
Intratracheal instillation of high dose adenoviral vectors is sufficient to
induce lung injury and fibrosis in mice. PLoS One 9(12):e116142. doi:10.
1371/journal.pone.0116142
89. Popova AP, Bentley JK, Anyanwu AC, Richardson MN, Linn MJ, Lei J, Wong
EJ, Goldsmith AM, Pryhuber GS, Hershenson MB (2012) Glycogen synthase
kinase-3beta/beta-catenin signaling regulates neonatal lung mesenchymal
stromal cell myofibroblastic differentiation. American journal of physiology
Lung cellular and molecular physiology 303(5):L439–L448. doi:10.1152/
ajplung.00408.2011
90. Hummler SC, Rong M, Chen S, Hehre D, Alapati D, Wu S (2013) Targeting
glycogen synthase kinase-3beta to prevent hyperoxia-induced lung injury in
neonatal rats. Am J Respir Cell Mol Biol 48(5):578–588. doi:10.1165/rcmb.
2012-0383OC
91. Li J, Yu KH, Oehlert J, Jeliffe-Pawlowski LL, Gould JB, Stevenson DK, Snyder
M, Shaw GM, O’Brodovich HM (2015) Exome sequencing of neonatal blood
spots and the identification of genes implicated in bronchopulmonary
dysplasia. Am J Respir Crit Care Med 192(5):589–596. doi:10.1164/rccm.
201501-0168OC
92. Xu W, Zhao Y, Zhang B, Xu B, Yang Y, Wang Y, Liu C (2015) Wnt3a mediates
the inhibitory effect of hyperoxia on the transdifferentiation of AECIIs to
AECIs. The journal of histochemistry and cytochemistry: official journal of
the Histochemistry Society 63(11):879–891. doi:10.1369/0022155415600032
93. Flozak AS, Lam AP, Russell S, Jain M, Peled ON, Sheppard KA, Beri R, Mutlu
GM, Budinger GR, Gottardi CJ (2010) Beta-catenin/T-cell factor signaling is
activated during lung injury and promotes the survival and migration of
alveolar epithelial cells. J Biol Chem 285(5):3157–3167. doi:10.1074/jbc.M109.
070326
94. Mutze K, Vierkotten S, Milosevic J, Eickelberg O, Konigshoff M (2015) Enolase
1 (ENO1) and protein disulfide-isomerase associated 3 (PDIA3) regulate
Wnt/beta-catenin-driven trans-differentiation of murine alveolar epithelial
cells. Disease models & mechanisms 8(8):877–890. doi:10.1242/dmm.019117
95. Alapati D, Rong M, Chen S, Lin C, Li Y, Wu S (2013) Inhibition of LRP5/6-
mediated Wnt/beta-catenin signaling by Mesd attenuates hyperoxia-
induced pulmonary hypertension in neonatal rats. Pediatr Res 73(6):719–
725. doi:10.1038/pr.2013.42
96. Filbrun AG, Popova AP, Linn MJ, McIntosh NA, Hershenson MB (2011)
Longitudinal measures of lung function in infants with bronchopulmonary
dysplasia. Pediatr Pulmonol 46(4):369–375. doi:10.1002/ppul.21378
97. Gough A, Linden M, Spence D, Patterson CC, Halliday HL, McGarvey LP
(2014) Impaired lung function and health status in adult survivors of
bronchopulmonary dysplasia. The European respiratory journal 43(3):808–
816. doi:10.1183/09031936.00039513
98. Tonson la Tour A, Spadola L, Sayegh Y, Combescure C, Pfister R, Argiroffo CB,
Rochat I (2013) Chest CT in bronchopulmonary dysplasia: clinical and radiological
correlations. Pediatr Pulmonol 48(7):693–698. doi:10.1002/ppul.22714
99. Walkup LL, Tkach JA, Higano NS, Thomen RP, Fain SB, Merhar SL, Fleck RJ,
Amin RS, Woods JC (2015) Quantitative magnetic resonance imaging of
bronchopulmonary dysplasia in the neonatal intensive care unit
environment. Am J Respir Crit Care Med 192(10):1215–1222. doi:10.1164/
rccm.201503-0552OC
100. Laughon MM (2014) Vitamin A shortage and risk of bronchopulmonary
dysplasia. JAMA Pediatr 168(11):995–996. doi:10.1001/jamapediatrics.2014.1416
101. Hutten MC, Wolfs TG, Kramer BW (2016) Can the preterm lung recover from
perinatal stress? Molecular and cellular pediatrics 3(1):15. doi:10.1186/
s40348-016-0043-9
102. Couroucli XI, Placencia JL, Cates LA, Suresh GK (2016) Should we still use
vitamin A to prevent bronchopulmonary dysplasia? Journal of perinatology:
official journal of the California Perinatal Association 36(8):581–585. doi:10.
1038/jp.2016.76
103. Crosby LM, Waters CM (2010) Epithelial repair mechanisms in the lung.
American journal of physiology Lung cellular and molecular physiology
298(6):L715–L731. doi:10.1152/ajplung.00361.2009
104. Alapati D, Rong M, Chen S, Hehre D, Hummler SC, Wu S (2014) Inhibition of
beta-catenin signaling improves alveolarization and reduces pulmonary
hypertension in experimental bronchopulmonary dysplasia. Am J Respir Cell
Mol Biol 51(1):104–113. doi:10.1165/rcmb.2013-0346OC
105. Huang SX, Islam MN, O’Neill J, Hu Z, Yang YG, Chen YW, Mumau M, Green
MD, Vunjak-Novakovic G, Bhattacharya J, Snoeck HW (2014) Efficient
generation of lung and airway epithelial cells from human pluripotent stem
cells. Nat Biotechnol 32(1):84–91. doi:10.1038/nbt.2754
106. Firth AL, Menon T, Parker GS, Qualls SJ, Lewis BM, Ke E, Dargitz CT, Wright R,
Khanna A, Gage FH, Verma IM (2015) Functional gene correction for cystic
fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep
12(9):1385–1390. doi:10.1016/j.celrep.2015.07.062
Ota et al. Molecular and Cellular Pediatrics  (2016) 3:34 Page 13 of 13
